Keyphrases
Survival Outcomes
100%
Thromboembolism
100%
Radical Cystectomy
100%
Bleeding Outcomes
100%
Tranexamic Acid
100%
Perioperative Blood Transfusion
50%
Overall Survival
42%
Cancer-specific Survival
42%
Venous Thromboembolism
28%
Postoperative Bleeding
14%
Estimated Blood Loss
14%
Mayo Clinic
7%
Multivariable
7%
Blood Transfusion
7%
Neoadjuvant Chemotherapy
7%
Between-group
7%
Pathological Stage
7%
Deep Vein Thrombosis
7%
Pulmonary Embolism
7%
Survival Model
7%
Bladder Cancer
7%
Oncological Outcomes
7%
Univariable Analysis
7%
Model Use
7%
Preoperative Hemoglobin
7%
Nursing and Health Professions
Bleeding
100%
Cystectomy
100%
Thromboembolism
100%
Tranexamic Acid
100%
Perioperative
64%
Blood Transfusion
57%
Overall Survival
42%
Cancer Specific Survival
42%
Venous Thromboembolism
21%
Deep Vein Thrombosis
7%
Lung Embolism
7%
Bladder Cancer
7%
Neoadjuvant Chemotherapy
7%
Medicine and Dentistry
Bleeding
100%
Thromboembolism
100%
Cystectomy
100%
Tranexamic Acid
100%
Blood Transfusion
57%
Overall Survival
42%
Cancer Specific Survival
42%
Venous Thromboembolism
21%
Neoadjuvant Chemotherapy
7%
Deep Vein Thrombosis
7%
Pulmonary Embolism
7%
Bladder Cancer
7%
Primary Outcome
7%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
100%
Thromboembolism
100%
Tranexamic Acid
100%
Overall Survival
42%
Cancer Specific Survival
42%
Venous Thromboembolism
21%
Chemotherapy
7%
Deep Vein Thrombosis
7%
Lung Embolism
7%
Bladder Cancer
7%